TIMP-2 Modulates Neointimal Formation in Experimental ePTFE Arterial Grafts

Journal of Surgical Research

Volumn 137, Issue 1, 2007, Pages 122-129

  Cavallaro, Giuseppe ^a   Cucina, Alessandra ^a   Randone, Bruto ^a   Polistena, Andrea ^a   Mosiello, Giovanni ^a   Coluccia, Pierpaolo ^a   De Toma, Giorgio ^a   Cavallaro, Antonino ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

ePTFE grafts; extracellular matrix; TIMP 2

Indexed keywords

GELATINASE A; POLITEF; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ABDOMINAL AORTA; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY GRAFT; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL DENSITY; CELL PROLIFERATION; CONTROLLED STUDY; INTIMA; MALE; NONHUMAN; POLITEF IMPLANT; PRIORITY JOURNAL; RAT; RAT STRAIN; SMOOTH MUSCLE FIBER; THORACIC AORTA;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; AORTA, ABDOMINAL; BLOOD VESSEL PROSTHESIS; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 2; MUSCLE, SMOOTH, VASCULAR; POLYTETRAFLUOROETHYLENE; POSTOPERATIVE COMPLICATIONS; RATS; RATS, INBRED LEW; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TUNICA INTIMA;

EID: 33845332033     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2006.07.038     Document Type: Article

References (28)

1. Merzirch L., Davies N., and Zilla P. Engineering of vascular in growth matrices: Are protein domains an alternative to peptides?. Anat Rec 263 (2001) 379
2. Randone B., Cavallaro G., Polistena A., et al. Dual role of VEGF in pretreated experimental ePTFE arterial grafts. J Surg Res 127 (2005) 70
3. Kuzuya M., and Iguchi A. Role of matrix metalloproteinases in vascular remodeling. J Atheroscl Thromb 10 (2003) 275
4. Kubota Y., Kleiman H.K., Martin G.R., and Lawley T.J. Role of laminin and basement membrane in the morphologic differentiation of human endothelial cells into capillary-like structures. J Cell Biol 107 (1988) 1589
5. Kuzuya M., Kanda S., Sasaki T., et al. Deficiency of gelatinase A suppresses smooth muscle cell invasion and development of experimental intimal hyperplasia. Circulation 108 (2003) 1375
6. de Smeth B.J., de Kleijn D., Hanemaaijer R., et al. Metalloproteinase inhibition reduces constrictive arterial remodeling after balloon angioplasty: A study in the atherosclerotic Yucatan micropig. Circulation 101 (2000) 2962
7. Zempo N., Koyama N., Kenagy R.D., Lea H.J., and Clowes A.W. Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor. Arterioscler Thromb Vasc Biol 16 (1996) 28
8. Bendeck M.P., Irvin C., and Reidy M.A. Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury. Circ Res 78 (1996) 38
9. Porter K.E., Loftus I.M., Peterson M., Bell P.R., London N.J., and Thompson M.M. Maristamat inhibits neointimal thickening in a model of human vein graft stenosis. Br J Surg 85 (1998) 1373
10. Brew K., Dinakarpandian D., and Nagase H. Tissue inhibitors of metalloproteinases: Evolution, structure and function. Biochim Biophys Acta 1477 (2000) 267
11. George S.J., Baker A.H., Angelini G.D., and Newby A.C. Gene transfer of tissue inhibitor of metalloproteinase-2 inhibits metalloproteinase activity and neointima formation in human saphenous veins. Gene Ther 5 (1998) 1552
12. Meinhart J.G., Deutsch M., Fischlein T., Howanietz N., Froschl A., and Zilla P. Clinical autologous in vitro endothelialization of 153 infrainguinal ePTFE grafts. Ann Thorac Surg 71 Suppl. 5 (2001) S327
13. Anderson J., Price T., Hanson S., and Harker L. In vitro endothelization of small caliber vascular grafts. Surgery 101 (1987) 577
14. Visse R., and Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry. Circ Res 92 (2003) 827
15. Galis Z.S., and Khatri J.J. Matrix metalloproteinases in vascular remodeling and atherosclerosis: The good, the bad, and the ugly. Circ Res 90 (2002) 251
16. Coats Jr. W.D., Whittaker P., Cheung D.T., Currier J.W., Han B., and Faxon D.P. Collagen content is significantly lower in restenotic versus nonrestenotic vessels after balloon angioplasty in the atherosclerotic rabbit model. Circulation 95 (1997) 1293
17. Moore G., Liao S., Curci J.A., et al. Suppression of experimental abdominal aortic aneurysm by systemic treatment with a hydroxamate-based matrix metalloproteinase inhibitor (RS 132908). J Vasc Surg 29 (1999) 522
18. Waller J.R., Bicknell G.R., and Nicholson M.L. Sirolimus attenuates the expression of metalloproteinase-2 and -9 and inhibits intimal hyperplasia following balloon angioplasty. Transplant Proc 34 (2002) 2881
19. Bendeck M.P., Zempo N., Clowes A.W., Galardy R.E., and Reidy M.A. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res 75 (1994) 539
20. Southgate K.M., Davies M., Booth R.F., and Newby A.C. Involvement of extracellular-matrix-degrading metalloproteinases in rabbit aortic smooth-muscle cell proliferation. Biochem J 288 (1992) 93
21. Baker A.H., Zaltsman A.B., George S.J., and Newby A.C. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro: TIMP-3 promotes apoptosis. J Clin Invest 101 (1998) 1478
22. Southgate K.M., Fisher M., Bannig A.P., et al. Upregulation of basement membrane-degrading metalloproteinase secretion after balloon injury of pig carotid arteries. Circ Res 79 (1996) 1177
23. Hojo Y., Ikeda U., Katsuki T., Mizuno O., Fujikawa H., and Shimada K. Matrix metalloproteinase expression in the coronary circulation induced by coronary angioplasty. Atherosclerosis 16 (2002) 185
24. Pasterkamp G., Schoneveld A.H., Hijnen D.J., et al. Atherosclerotic arterial remodelling and the localization of macrophages and matrix metalloproteinases 1, 2 and 9 in the human coronary artery. Atherosclerosis 150 (2000) 245
25. Sterpetti A.V., Cucina A., Lepidi S., et al. Progression and regression of myointimal hyperplasia in experimental vein grafts depends on platelet-derived growth factor and basic fibroblastic growth factor production. J Vasc Surg 23 (1996) 568
26. Jawien A., Bowen-Pope D.F., Lindner V., Schwartz S.M., and Clowes A.W. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest 89 (1992) 507
27. Horstmann S., Kalb P., Koziol J., Gardner H., and Wagner S. Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients. Influence of different therapies. Stroke 34 (2003) 2165
28. Young-Min S.A., Beeton C., Laughton R., et al. Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controls. Ann Rheum Dis 60 (2001) 846